The stock has experienced a volatile uptrend over the past year, with a 1-year price change of +82.8%, significantly outperforming the S&P 500's +19.1%. However, the current price of $19.58 sits at just 30% of its 52-week range ($7.78–$46.75), indicating a sharp pullback from the May highs near $46. This positioning near the low end of the range suggests the stock is in a correction phase, potentially offering a value entry if the long-term uptrend resumes, but also reflecting waning momentum. The 52-week low of $7.78 provides a critical support level, while the high of $46.75 represents major resistance.

Revenue in the most recent quarter (Q4 2025) was $44.8 million, down 18.6% year-over-year from $55.0 million in Q4 2024, marking a deceleration from the prior quarter's $52.4 million. The company reported a net loss of $40.0 million in Q4 2025, compared to a net loss of $148.7 million in Q4 2024, but the loss widened sequentially from Q3 2025's net loss of $6.8 million. Gross margin improved to 30.2% in Q4 2025 from 68.1% in Q4 2024, though the prior year's margin was inflated by a one-time gain. Operating margin remained deeply negative at -73.9% in Q4 2025, reflecting high SG&A costs ($40.2 million) relative to revenue. The company is not yet profitable, with a trailing twelve-month net loss of $96.8 million, though the loss has narrowed from the prior year's $284.4 million loss. Free cash flow was negative $22.9 million in Q4 2025, and the company has a debt-to-equity ratio of -0.50, indicating negative equity (liabilities exceed assets). However, the current ratio of 4.96 suggests strong short-term liquidity, supported by $585.3 million in cash at the end of Q4 2025. ROE of 11.1% is positive due to negative equity, which is a distortion; ROA of -5.4% reflects ongoing operating losses.